Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_assertion type Assertion NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_head.
- NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_assertion description "[ These data provide the first evidence suggesting that polymorphism of the GSTM3 gene contributes to clinical severity in CF, which may have prognostic significance and could prompt to start a more targeted therapy in young patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_provenance.
- NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_assertion evidence source_evidence_literature NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_provenance.
- NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_assertion SIO_000772 15115915 NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_provenance.
- NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_assertion wasDerivedFrom gad-20150221 NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_provenance.
- NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_assertion wasGeneratedBy ECO_0000203 NP50789.RAlLde4txHwG0DJ3i6aiZxbiP8tExi7QKEwoipo6X63Gk130_provenance.